History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 3, 2008, Pages 777-782

  Brunelli, Steven M ^a   Joffe, Marshall M ^a   Israni, Rubeen K ^a   Yang, Wei ^a   Fishbane, Steven ^b   Berns, Jeffrey S ^a   Feldman, Harold I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN;

AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; TIME;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, STATISTICAL; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 44649192544     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04281007     Document Type: Article

References (28)

1. Berns JS, Elzein H, Lynn RI, Fishbane S, Mesisels IS, Deoreo PB: Hemoglobin variability in epoetin-treated hemodialysis patients. Kidney Int 64: 1514-1521, 2003
2. Ebben JP, Gilbertson DT, Foley RN, Collins AJ: Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 1: 1205-1210, 2006
3. Fishbane S, Berns JS: Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68: 1337-1343, 2005
4. Lacson E, Ofsthun N, Lazarus JM: Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 41: 111-124, 2003
5. Yang W, Israni RK, Brunelli SM, Joffe M, Fishbane S, Feldman HI: Variation in hemoglobin level in patients with end stage renal disease and anemia. J Am Soc Nephrol 18: 1364-1370, 2007
6. Robins JM, Blevins D, Ritter G, Wulfsohn M: G-estimation of the effect of prophylactic therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology 3: 319-336, 1992
7. Robins JM: A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. J. Chronic Dis. 40[Suppl 2]: 139s-161s, 1987
8. Robins JM, Hernan MA, Brumback B: Marginal structural models and causal inference in epidemiology. Epidemiology 11: 550-560, 2000
9. Rothman KJ, Greenland S. Types of Epidemiologic Study. In: Modern Epidemiology, edited by Rothman KJ, Greenland, S. Philadelphia, Lippincott Williams & Wilkins, 1998, pp 67-78
10. Robins JM: Correction for non-compliance in equivalence trials. Statistical Med. 17: 269-302, 1998
11. Hernan MA, Brumback B, Robins JM: Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 11: 561-570, 2000
12. Neugebauer R, van der Laan MJ, Joffe MM, Tager IB: Causal inference in longitudinal studies with history-restricted marginal structural models. Elec J Stats 1: 119-154, 2007
13. Elliott MR, Little RJA: Model-based alternatives to trimming survey weights. J Official Stats 16: 191-209, 2000
14. Ofsthun N, Labrecque J, Lacson E, Keen M, Lazarus JM: The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 63: 1908-1914, 2003
15. Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K: Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 17: 1181-1191, 2006
16. Gilbertson DT, Ebben JP, Collins AJ: The effect of hemoglobin variability on hospitalization and mortality [Abstract]. ERD_EDTA Congress. Glasgow, United Kingdom, 2006
17. Gilbertson DT, Ebben JP, Collins AJ: The effect of hemoglobin variability on hospitalization and mortality [Abstract]. Am Soc Nephrol. San Diego, CA, 2006
18. Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D: Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16: 2180-2189, 2005
19. Besarab A, Bolton WK, Brown JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590, 1998
20. Cook NR, Cole SR, Hennekens CH: Use of marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. Am J Epidemiol 155: 1045-1053, 2002
21. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA, Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16: 1115-1125, 2005
22. Feldman HI, Joffe M, Robinson B, Knauss J, Cizman B, Guo W, Franklin-Becker E, Faich G: Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 15: 1623-1632, 2004
23. Weinhandl ED, Rao M, Gilbertson DT, Collins AJ, Pereira BJG: Protective effect of intravenous levocarnitin on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003. Am J Kidney Dis 50: 803-812, 2007
24. Habler OP, Messmer KF: The physiology of oxygen transport. Transfus Sci 18: 425-435, 1997
25. Georgieva Z, Georgieva M: Compensatory and adaptive changes in microcirculation and left ventricular function in patients with chronic iron-deficiency anemia. Clin Hemorheol Microcirc 17: 21-30, 1997
26. Meerson FZ, Evsevieva ME: Disturbances of the heart structure and function in chronic hemolytic anemia, their compensation with increased coronary flow, and their prevention with ionol, an inhibitor of lipid peroxidation. Adv Myocardial 5: 201-211, 1985
27. Romero Mestre JC, Hernandez A, Agramonte O, Hernandez P: Cardiovascular autonomic dysfunction in sickle cell anemia: A possible risk factor for sudden death? Clin Auton Res 7: 121-125, 1997
28. Romero-Vecchione E, Perez O, Wessolosky M, Rosa F, Liberatore S, Vasquez J: Abnormal autonomic cardiovascular responses in patients with sickle cell anemia. Sangre 40: 393-399, 1995